GB201609758D0 - Dosing Regimen - Google Patents

Dosing Regimen

Info

Publication number
GB201609758D0
GB201609758D0 GBGB1609758.6A GB201609758A GB201609758D0 GB 201609758 D0 GB201609758 D0 GB 201609758D0 GB 201609758 A GB201609758 A GB 201609758A GB 201609758 D0 GB201609758 D0 GB 201609758D0
Authority
GB
United Kingdom
Prior art keywords
dosing regimen
regimen
dosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1609758.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cyclacel Ltd
Original Assignee
Cyclacel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclacel Ltd filed Critical Cyclacel Ltd
Priority to GBGB1609758.6A priority Critical patent/GB201609758D0/en
Publication of GB201609758D0 publication Critical patent/GB201609758D0/en
Priority to PCT/GB2017/051597 priority patent/WO2017208019A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
GBGB1609758.6A 2016-06-03 2016-06-03 Dosing Regimen Ceased GB201609758D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1609758.6A GB201609758D0 (en) 2016-06-03 2016-06-03 Dosing Regimen
PCT/GB2017/051597 WO2017208019A1 (en) 2016-06-03 2017-06-02 Dosing regimen for sapacitabin and seliciclib

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1609758.6A GB201609758D0 (en) 2016-06-03 2016-06-03 Dosing Regimen

Publications (1)

Publication Number Publication Date
GB201609758D0 true GB201609758D0 (en) 2016-07-20

Family

ID=56508050

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1609758.6A Ceased GB201609758D0 (en) 2016-06-03 2016-06-03 Dosing Regimen

Country Status (2)

Country Link
GB (1) GB201609758D0 (en)
WO (1) WO2017208019A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9872874B2 (en) * 2012-05-15 2018-01-23 Cyclacel Limited Dosage regimen for sapacitabine and seliciclib

Also Published As

Publication number Publication date
WO2017208019A1 (en) 2017-12-07

Similar Documents

Publication Publication Date Title
SI3347054T1 (en) Dosing regimens for anti-tf-antibody drug-conjugates
GB201713653D0 (en) Dosage regimen
HK1257131A1 (en) Dosing device
HK1259491A1 (en) Dosing regimens
HRP20181570T1 (en) Fgf-18 compound dosing regimen
IL273419A (en) Dosing regimen of siponimod
GB201418710D0 (en) Dosage regimen
IL273382A (en) Dosing regimen of siponimod
GB201516836D0 (en) Dosing regimen of combination
IL266255A (en) Novel dosage regimen
GB201720519D0 (en) Dosing regimen
GB201718106D0 (en) Dosing regimen
GB201718000D0 (en) Dosing regimen
GB201717694D0 (en) Dosing regimen
GB201609758D0 (en) Dosing Regimen
GB201713224D0 (en) Regimen
GB201617850D0 (en) Dosage regimen
GB201614232D0 (en) Regimen
GB201610502D0 (en) Dosage regimen
GB201521216D0 (en) Dosage regimen
GB201611236D0 (en) Dosing tubes
GB201600935D0 (en) Dosing device
GB201418708D0 (en) Dosage regimen
GB201400171D0 (en) Dosage regimen

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)